Anastrozole Tablet
Product Images NDC 68071-4038

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 68071-4038). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

68071 4038 3

Packaging label for Anastrozole 1 mg tablets by NuCare Pharmaceuticals, Inc. The label shows the NDC 68071-4038-3, indicates a quantity of 30 tablets, and states prescription use only. It includes storage instructions to keep at controlled temperature 68-77°F and warnings to keep out of reach of children. The label references the manufacturer Natco Pharma Limited in India.*

FDA Label Image

Pdp (Anas.grp1)

A Kaplan-Meier survival curve chart comparing disease-free survival over months between patients treated with anastrozole and tamoxifen. The y-axis represents the proportion alive and disease-free, and the x-axis shows time in months up to 96. A table beneath the graph displays the number of patients at risk for each treatment group at various time points.*

FDA Label Image

Anastrozole Tablets Graph2 (Anas.grp2)

A survival curve chart comparing disease-free survival in months for patients treated with anastrozole versus tamoxifen. The vertical axis shows the proportion alive and disease-free from 0.0 to 1.0, and the horizontal axis shows time in months up to 96. Two lines represent randomized treatment groups: a dashed line for anastrozole and a solid line for tamoxifen. Below the graph, a table lists the number of patients at risk over time for each treatment group.*

FDA Label Image

Anastrozole Tablets Graph3 (Anas.grp3)

A Kaplan-Meier survival curve chart comparing two groups labeled "VOLUME REDUCTION" and "ASSOCIATED" over a time period of up to 36 months. The y-axis represents the percent of presence, and the x-axis represents time in months. Data points show a decline in percent presence for both groups over time, with the VOLUME REDUCTION group consistently showing higher values than the ASSOCIATED group.*

FDA Label Image

Anastrozole Tablets Graph4 (Anas.grp4)

A Kaplan-Meier survival curve showing proportion progression-free over time in months for two groups, labeled 'Anastrozole' and 'Tamoxifen,' depicting comparative progression-free survival rates.*

FDA Label Image

Anastrozole Chemical Structure (Anas.str)

Chemical structure diagram of anastrozole, showing its molecular framework with aromatic rings and nitrogen-containing triazole groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.